Diagnosis of clinical infection of a wound
View Patent ↗A method of predicting or diagnosing clinical infection of a wound comprising measuring the concentration of a marker associated with an inflammatory response in wound fluid, wherein the marker is a fibronectin fragment, a neutrophil protease or a macrophage protease. Also provided is a use of a wound dressing or biosensor comprising components of an assay system for measuring the concentration of a marker associated with an inflammatory response, wherein the marker is a fibronectin fragment, a neutrophil protease or a macrophage protease, for use in the manufacture of a medicament for predicting the likelihood of clinical infection of the wound or for diagnosing clinical infection of a wound.
1. A method of predicting or diagnosing clinical infection of a chronic wound comprising measuring a concentration of a neutrophil elastase in wound fluid from the chronic wound, comparing the concentration to a basal level concentration of a neutrophil elastase, and determining if the concentration is at or above a level indicative of clinical infection or subsequent progression of the chronic wound to clinical infection; wherein the concentration of the neutrophil elastase is measured by a dip-stick type test; wherein a concentration from about 1.5-fold to about 16.0-fold the basal level concentration is indicative of clinical infection; and wherein a concentration from about 1.5-fold to 9.0-fold the basal level concentration is indicative of subsequent progression to clinical infection.
2. The method according to claim 1 wherein the chronic wound is a chronic ulcer.
3. The method of claim 2 wherein the chronic ulcer is a dermal ulcer, venous ulcer, pressure sore, or decubitis ulcer.
4. The method according to claim 1 wherein the concentration of the neutrophil elastase is measured using an immunological, spectrophotometric, colorimetric, fluorimetric, or radioactive detection based technique.
5. The method of claim 1 wherein the measuring is performed on a sample of the wound fluid that has been removed from the body of a patient.
6. The method of claim 1 wherein the method is for predicting clinical infection of a chronic wound and determining if the concentration is at or above a level indicative of subsequent progression of the chronic wound from non-clinical to clinical infection.
7. The method according to claim 6 wherein the chronic wound is a chronic ulcer.
8. The method of claim 7 wherein the chronic ulcer is a dermal ulcer, venous ulcer, pressure sore, or decubitis ulcer.
9. The method according to claim 6 wherein the concentration of the neutrophil elastase is measured using an immunological, spectrophotometric, colorimetric, fluorometric, or radioactive detection based technique.
10. The method of claim 6 wherein the measuring is performed on a sample of the wound fluid that has been removed from the body of a patient.